Cerliponase alfa

N/A

Report date: 2024/07/30 10:23:38
First In Class

Base Information

Drug NameCerliponase alfa
Drug Alias NamerhTPP1recombinant human tripeptidyl peptidase-1BrineuraBMN-190
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionTripeptidyl peptidase 1 replacements
TargetsNot applicable
Therapy Area/IndicationsNeuronal ceroid lipofuscinosis type 2Neuronal Ceroid-Lipofuscinoses
Global Approved IndicationsNeuronal Ceroid-Lipofuscinoses
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/04/27
Country/TerritoryUnited StatesItalyGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomarin Pharmaceutical IncBiomarin International Ltd
Inactive CompaniesN/A
Active IndicationsNeuronal ceroid lipofuscinosis type 2Neuronal Ceroid-Lipofuscinoses
Inactive IndicationsN/A

Other Information

ATC CodeA16AB17
Related LinksKEGG